Advertisement
Advertisement

TVRD

T

Tvardi Therapeutics, Inc. Common Stock

4.18
USD
Sponsored
-0.03
-0.71%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

4.22

+0.04
+1.08%

Tvardi Therapeutics, Inc. Common Stock Profile

About

Tvardi Therapeutics Inc. is a privately held, clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Tvardi Therapeutics Inc., formerly known as Cara Therapeutics Inc., is based in STAMFORD, Conn.

Info & Links

CEO

Imran Alibhai

Headquarters

3 SUGAR CREEK CTR. BLVD., STE 525
SUGAR LAND, TX 77478, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.tvarditherapeutics.com

Auditor

Deloitte & Touche LLP

Share holders

127

Employees

12

Tvardi Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

39.64M

Enterprise Value

18.90M

Enterprise Value/EBITDA(ttm)

-0.78

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-186.10%

Return on Equity(ttm)

-73.53%

Return on Invested Capital(ttm)

99.07%

Return on Assets(ttm)

-35.22%

Income Statement

Revenue(ttm)

2.57M

Revenue Per Share(ttm)

0.27

Gross Profit(ttm)

2.57M

EBITDA(ttm)3

-24.33M

Net Income Available to Common(ttm)

-18.21M

Diluted EPS(ttm)

-5.59

Share Statistics

Beta (5Y Monthly)

0.16

52-Week Change

-83.95%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.38M

Dividend Yield

0.00%

Float4

9.09M

% Held by Insiders

3.10%

% Held by Institutions

44.66%

Balance Sheet

Total Cash(mrq)

30.81M

Total Cash Per Share(mrq)

3.28

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.48%

Quick Ratio(mrq)

2.86%

Book Value Per Share(mrq)

2.97

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.90

Free Cash Flow(ytd)

-17.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement